← Exxon Mobil Corporation

XOM · Forward model · Guyana case

The Guyana case, 20 quarters out

Model as of

Each segment is projected from its own operating driver, rolled up into consolidated cash flow, and discounted back to a fair value per share. The assumptions below are editable — change them and every number on this page moves with them.

Five verticals - the four reportable segments net of intersegment eliminations plus the Corporate-and-Financing non-segment line - are the finest honest cut. They sum to reported Total revenues and other income to the dollar in all ten quarters from 2024 Q1 to 2026 Q2, which is the whole history available on this presentation: the segment note carrying the reconciling basis begins with the 2025 filings, whose comparatives reach 2024 Q1. Two quarters are marked estimated, 2024 Q4 and 2025 Q4, because they were derived by subtracting a nine-month figure from a full-year one; both reconcile to the quarterly revenue already stored in data/companies/xom/series.json. No Permian-versus-Guyana split, no refining-versus-trading split and no polyethylene-versus-performance-chemicals split is attempted, because none is disclosed. Low Carbon Solutions has no revenue line at all and is not given one. Disclosed and copied as reported: segment revenue, segment volumes, realisations and markers, per-segment cash capex, the annual earnings sensitivities, the 3Q26 key items and the 2026 and 2030 volume, capex, cost-savings and buyback plans. Assumed and labelled as such: every forward price path, the terminal margins and capex intensities, the 30% tax rate, the 9% discount rate and the 9.0x exit multiple. All five verticals are aseasonal. Fourteen quarters of per-segment third-party sales across three calendar-year windows were tested and no vertical produced a factor whose deviation from 1.0 exceeded its own window-to-window spread - the largest signal is Upstream Q3 at 5.0% against a 66-point spread - so no seasonality vector is asserted. Two arithmetic artefacts are worth stating plainly. Upstream EBITDA is 127% of Upstream reported revenue in the basis quarter because transferred barrels sit in the numerator and not the denominator; the margin is capped at 100% and the $3,664M the cap cannot hold is credited to Energy Products, which buys those barrels, so consolidated EBITDA still reconciles. And the disclosed per-tonne unit-earnings figures for Chemical and Specialty Products cannot be reconciled to reported segment earnings - ~$210/T on 21.3 Mt would imply about $4.5B of 2025 Chemical earnings against the $800M the four 2025 quarters reported - so terminal margins are set from the reported segment note instead. Corporate overhead of 0.78% of revenue is the midpoint of the disclosed $0.8-1.0B of 3Q26 Corporate and Financing expenses. The share count is held flat at the 4,112M outstanding on 30 June; the disclosed ~$20B a year of buybacks would shrink it about 3.6% annually, so the per-share output here is conservative by roughly that much a year. Free cash flow in this model is EBITDA less capex less tax, which is not the company's own non-GAAP free cash flow of $17,236M for the quarter.

XOM forward model
Horizon
Fair value per share $171.03 +7% against $159.47
Terminal-year revenue $348.38B last four projected quarters
Enterprise value $735.06B $158.89B explicit + $576.17B terminal

The only asset-level economics disclosed this quarter, applied to the Upstream vertical alone. Co-venturers have invested more than $55B since 2014 and recovered it about two years ahead of the investment basis, generating more than $13B of incremental revenue and cost savings; the first four FPSOs run roughly 100 kbd above their original basis at about 98% reliability, the fifth sailed in June for 4Q26 startup with 250 kbd of capacity, and the company expects its share of Guyana free cash flow to more than double between 2025 and 2030. What this case does not achieve is the rest of the plan: Chemical and Specialty tonnage, the refining margin and the cost-savings target are all left exactly where the base case puts them, and the ~100 kbd entitlement step still lands in the first projected quarter.

XOM REVENUE MODEL

Latest: $87.76B (2031Q2E)

Period Value
2024Q1 $83.08B
2024Q2 $93.06B
2024Q3 $90.02B
2024Q4 $83.43B
2025Q1 $83.13B
2025Q2 $81.51B
2025Q3 $85.29B
2025Q4 $82.31B
2026Q1 $85.14B
2026Q2 $116.02B
2026Q3E $104.13B
2026Q4E $97.06B
2027Q1E $92.44B
2027Q2E $89.39B
2027Q3E $87.38B
2027Q4E $86.08B
2028Q1E $85.27B
2028Q2E $84.80B
2028Q3E $84.58B
2028Q4E $84.54B
2029Q1E $84.62B
2029Q2E $84.80B
2029Q3E $85.04B
2029Q4E $85.34B
2030Q1E $85.68B
2030Q2E $86.05B
2030Q3E $86.45B
2030Q4E $86.87B
2031Q1E $87.30B
2031Q2E $87.76B
Scenarios

Where each case comes from

Valuation

From cash flow to fair value

Present value of free cash flow, 20 quarters$158.89B
Terminal-year revenue$348.38B
Terminal-year EBITDA$93.32B
Exit multiple, on ebitda9.5x
Terminal value$886.51B
Discounted at 9.0% a year, terminal value becomes$576.17B
Share of enterprise value from the terminal78%
Enterprise value$735.06B
Net cash-$31.78B
Equity value$703.28B
Shares4.11B
Fair value per share$171.03
Against the deployed price of $159.47, as of +7%

9% is the cost of equity for an investment-grade major carrying $31.8B of net debt against $266.1B of equity. The 9.0x exit sits between the 9.3x the market pays on trailing EBITDA that contains the spike quarter and the 10.4x the same enterprise value implies against FY2025 EBITDA of $67.9B - and that is the whole argument, because the multiple you believe depends entirely on which EBITDA you think is normal.

Read the other way round: at $159.47 the market is paying 8.7x terminal-year revenue, holding every other assumption on this page fixed. That is the number to argue about.

Capital programmes

Capex outside the verticals

Each vertical's capex is a share of its own revenue, which is the right shape for capacity that scales with sales. These are not that: fixed-size programmes with their own schedule that spend whether or not any segment grows. They are added on top, and they are why free cash flow dips in the years below.

Other corporate cash capital expenditures

2026 Q3 → 2031 Q2
Programme total$1.80B
Cash out$90M/qtr

The Other line of the disclosed per-segment cash capex table: $90M in 2Q26 against $140M in 1Q26. It belongs to no vertical, so it is spread evenly across the twenty projected quarters at the basis-quarter rate rather than tied to a revenue ratio.

Quarter by quarter

The projected path

Quarter UpstreamEnergy ProductsChemical ProductsSpecialty ProductsCorporate and Financing Revenue YoY EBITDA Capex FCF R40 PV of FCF
2026 Q3E $12.37B$80.08B$6.59B$5.07B$24M $104.13B +22% $24.67B $6.77B $12.53B +34 $12.27B
2026 Q4E $12.14B$73.74B$6.26B$4.88B$24M $97.06B +18% $22.95B $6.88B $11.25B +30 $10.78B
2027 Q1E $12.07B$69.54B$6.03B$4.77B$24M $92.44B +9% $21.85B $6.93B $10.44B +20 $9.79B
2027 Q2E $12.10B$66.68B$5.87B$4.71B$24M $89.39B -23% $21.15B $6.97B $9.93B -12 $9.11B
2027 Q3E $12.21B$64.69B$5.77B$4.68B$24M $87.38B -16% $20.73B $7.03B $9.60B -5 $8.62B
2027 Q4E $12.37B$63.30B$5.71B$4.68B$24M $86.08B -11% $20.51B $7.10B $9.39B +0 $8.25B
2028 Q1E $12.57B$62.30B$5.68B$4.69B$24M $85.27B -8% $20.43B $7.20B $9.26B +3 $7.97B
2028 Q2E $12.80B$61.59B$5.68B$4.72B$24M $84.80B -5% $20.45B $7.30B $9.20B +6 $7.75B
2028 Q3E $13.06B$61.06B$5.69B$4.75B$24M $84.58B -3% $20.55B $7.43B $9.19B +8 $7.57B
2028 Q4E $13.34B$60.67B$5.71B$4.80B$24M $84.54B -2% $20.71B $7.56B $9.20B +9 $7.42B
2029 Q1E $13.64B$60.38B$5.74B$4.84B$24M $84.62B -1% $20.92B $7.70B $9.25B +10 $7.30B
2029 Q2E $13.95B$60.15B$5.78B$4.90B$24M $84.80B +0% $21.16B $7.85B $9.31B +11 $7.19B
2029 Q3E $14.27B$59.98B$5.82B$4.95B$24M $85.04B +1% $21.44B $8.01B $9.40B +12 $7.10B
2029 Q4E $14.61B$59.83B$5.87B$5.01B$24M $85.34B +1% $21.74B $8.18B $9.49B +12 $7.02B
2030 Q1E $14.96B$59.72B$5.92B$5.07B$24M $85.68B +1% $22.06B $8.35B $9.60B +12 $6.95B
2030 Q2E $15.32B$59.61B$5.97B$5.13B$24M $86.05B +1% $22.40B $8.52B $9.71B +13 $6.88B
2030 Q3E $15.69B$59.52B$6.02B$5.19B$24M $86.45B +2% $22.76B $8.71B $9.83B +13 $6.82B
2030 Q4E $16.07B$59.44B$6.07B$5.26B$24M $86.87B +2% $23.13B $8.89B $9.97B +13 $6.76B
2031 Q1E $16.46B$59.37B$6.13B$5.32B$24M $87.30B +2% $23.52B $9.08B $10.10B +13 $6.71B
2031 Q2E $16.86B$59.30B$6.19B$5.39B$24M $87.76B +2% $23.92B $9.28B $10.24B +14 $6.66B

Every row is projected. A year-over-year change is shown only where the quarter it compares against exists — an em dash means there is no comparable quarter, not a flat year.

Track record

Model revisions

Assumptions are marked to reality as each quarter prints. Every change is appended here, with the fair value the model produced at the time, so the model's own history stays visible.

DateFair value thenNote
2026-08-27 $150.65 First published model, built from the 2026 Q2 research brief: five reconciling verticals, four unit drivers on disclosed volumes and a growth line for Corporate and Financing.